ADOCIA a biotechnology company dedicated to protein delivery

  • Contact Us
  • Linkedin
  • RSS
  • LANGUAGES
    • English English
    • Français Français
  • Presentation
    • About Adocia
    • Founders
    • Management
    • Board of Directors
    • Team
    • Scientific Advisory Board
    • Symbol
  • Technology
    • BIOCHAPERONE®
    • Intellectual property
    • Publications
  • Products
    • Pipeline
    • BIOCHAPERONE® LISPRO
    • BIOCHAPERONE® COMBO
    • M1Pram
    • BIOCHAPERONE® GLUCAGON
    • BIOCHAPERONE® Gla GLP-1
    • BioChaperone® Glucagon GLP-1
  • Partnering
    • Licensing Opportunities
    • Contact
  • Financials
    • Home Investors
    • Regulated Information
    • Documentation
    • Shareholders
    • Shareholders meeting
    • Governance
    • Investors Contact
  • Careers
    • Working at Adocia
    • HR Policy
    • Spontaneous application
    • Offers
  • News & Events
    • Press Releases
    • Upcoming Events

“Physically glycosylating” proteins to enhance their performance

BioChaperone®: Innovative biopolymers inspired by Heparin

The capacity of heparin, a natural polysaccharide, to form molecular complexes with growth factors was discovered over a decade ago. This physical association through electrostatic interactions improves growth factor activity in three main ways:

  • Increasing growth factor solubility
  • Protecting the growth factor against enzymatic degradation
  • Extending the time of action of the growth factor

 

ADOCIA portfolio: more than 300 patented BioChaperone® molecules

BioChaperone® was “bio-inspired” by heparin with the aim of forming complexes with a large variety of proteins.

ADOCIA developed BioChaperone® in order to mimic the interactive properties of heparin with growth factors, without the anticoagulation properties specific to heparin.

The BioChaperone® platform now includes more than 300 innovative patented polymers, oligomers and small organic compounds. BioChaperone® polymers are for instance dextran-based molecules functionalized with natural amino acid and carboxylate.

Représentation de BioChaperone

BioChaperone® representation

BioChaperone® polymers, oligomers and small organic compounds can interact with proteins of interest to form physical complexes. Those interactions are reversible and do not modify the protein.

Technology

  • BioChaperone®
  • Intellectual property
  • Publications

BIOCHAPERONE® TECHNOLOGY

  • “Physically glycosylating” proteins
  • A versatile platform

A la Une / Spotlight

  • Adocia-Analyse Department

    France 3 Auvergne Rhône Alpes (French TV) broadcast: Adocia develops faster, more physiologic insulins to improve the lives of people with diabetes. Eve-Marie, T1D, shares her daily life struggles and her hopes for improved life with diabetes.

    In France, more than 3.5 million people live wi...
  • Gérard Soula, Adocia CEO

    BFM TV Broadcast in Adocia laboratory on World Diabetes Day: “Diabetes, an omnipresent disease which now affects one in eleven people worldwide”

    On World Diabetes Day, BFM TV highlighted “the ...

  • Home
  • Terms Of Use
  • Privacy Policy
  • Contact
ADOCIA a biotechnology company dedicated to protein delivery

Copyright ADOCIA © 2018

TOP
Cookies

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.